Related Experiment Videos
Development of a 5-hydroxytryptamine(2A) receptor binding assay for high throughput screening using 96-well
A Harms1, D Gündisch, C E Müller
1Pharmaceutical Institute, University of Tübingen, Tübingen, Germany.
Journal of Biomolecular Screening
|September 19, 2000
Summary
A new high-throughput screening method optimizes 5-hydroxytryptamine (5-HT2A) receptor binding analysis. This method enhances efficiency and accuracy for drug discovery research.
Area of Science:
- Pharmacology
- Neuroscience
- Biochemistry
Background:
- The 5-hydroxytryptamine (5-HT2A) receptor is a key target for neurological and psychiatric drug development.
- Accurate and efficient methods for analyzing receptor binding parameters are crucial for drug discovery.
Purpose of the Study:
- To develop and validate a high-throughput screening (HTS) method for analyzing 5-HT2A receptor binding.
- To optimize assay conditions for improved efficiency and reduced nonspecific binding.
Main Methods:
- Utilized 96-well Millipore MultiScreen filter plates (MAFB) with a MicroBeta PLUS microplate scintillation counter.
- Optimized filter type, scintillation cocktail, drying conditions, and presoaking with polyethyleneimine.
- Determined optimal protein concentration and receptor-radioligand equilibration times.
Main Results:
- MAFB filter plates and Betaplatescint cocktail yielded high counting efficiency and short equilibration times.
- Presoaking reduced nonspecific binding by 50%; removing the underdrain increased counting efficiency by 39%.
- Saturation analysis yielded Bmax of 393 fmol/mg protein and KD of 2.0 nM for [3H]ketanserin-HCl.
Conclusions:
- The developed HTS method is efficient and reliable for 5-HT2A receptor binding studies.
- Optimized conditions significantly reduce assay variability and improve data quality.
- This method facilitates rapid screening of potential therapeutic agents targeting the 5-HT2A receptor.